持股变动声明
Nephros(NEPH)03-15 04:35
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011 Size: 6 KB 网页链接
简介:Nephros, Inc.于1997年4月3日根据特拉华州法律注册成立。该公司是一家商业级公司,为医疗器械和商业市场开发和销售高性能水净化产品。在医疗器械市场, 他们的过滤器,通常被归类为超滤器,主要由医院用于预防水传播病原体感染。在商业市场,该公司生产和销售改善水的味道和气味并减少生物膜,细菌和规模的过滤器 在下游设备中积聚。
今开:2.4 | 昨收:2.36 |
最高:2.5401 | 最低:2.2881 |
涨停价: | 跌停价: |
总市值:24146078 |
Nephros(NEPH)03-15 04:35
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000011 Size: 6 KB 网页链接
Nephros(NEPH)04-13 04:05
$Nephros(NEPH)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-014442 Act: 34 Size: 1 MB 网页链接
Nephros(NEPH)05-10 04:45
$Nephros(NEPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-018483 Act: 34 Size: 3 MB 网页链接
Nephros(NEPH)05-01 20:05
$Nephros(NEPH)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-24-017355 Act: 34 Size: 11 MB 网页链接
Nephros(NEPH)03-15 04:45
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001048462-24-000012 Size: 12 KB 网页链接
Nephros(NEPH)05-11 04:25
$Nephros(NEPH)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-018645 Act: 33 Size: 954 KB 网页链接
Nephros(NEPH)05-17 04:35
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010455 Size: 12 KB 网页链接
Nephros(NEPH)05-17 04:55
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010486 Size: 8 KB 网页链接
Nephros(NEPH)03-16 04:35
$Nephros(NEPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-010107 Act: 34 Size: 7 MB 网页链接
Nephros(NEPH)05-17 04:25
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010451 Size: 8 KB 网页链接
蹊之美股生物医药2021-07-09 20:55
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aerpio Pharm (ARPO) +63.16%
GBS Inc (GBS) +33.22%
Alterity Therapeutics (ATHE) +27.85%
9 Meters Biopharma (NMTR) +20.39%
F-star Therapeutics (FSTX) +9.13%
Los...查看全文
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010486 Size: 8 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010453 Size: 13 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010455 Size: 12 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010460 Size: 5 KB 网页链接
$Nephros(NEPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010451 Size: 8 KB 网页链接
$Nephros(NEPH)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-018645 Act: 33 Size: 954 KB 网页链接
$Nephros(NEPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-018483 Act: 34 Size: 3 MB 网页链接
$Nephros(NEPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-018435 Act: 34 Size: 314 KB 网页链接
$Nephros(NEPH)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-24-017355 Act: 34 Size: 11 MB 网页链接
$Nephros(NEPH)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-24-014447 Act: 34 Size: 709 KB 网页链接